Global Acyclovir Sodium Injection Market Research Report 2022
1 Acyclovir Sodium Injection Market Overview
- 1.1 Product Overview and Scope of Acyclovir Sodium Injection
- 1.2 Acyclovir Sodium Injection Segment by Type
- 1.2.1 Global Acyclovir Sodium Injection Sales Growth Rate Comparison by Type (2022-2028)
2 Acyclovir Sodium Injection Market Competition by Manufacturers
- 2.1 Global Acyclovir Sodium Injection Sales Market Share by Manufacturers (2017-2022)
- 2.2 Global Acyclovir Sodium Injection Revenue Market Share by Manufacturers (2017-2022)
- 2.3 Global Acyclovir Sodium Injection Average Price by Manufacturers (2017-2022)
- 2.4 Manufacturers Acyclovir Sodium Injection Manufacturing Sites, Area Served, Product Type
- 2.5 Acyclovir Sodium Injection Market Competitive Situation and Trends
- 2.5.1 Acyclovir Sodium Injection Market Concentration Rate
3 Acyclovir Sodium Injection Retrospective Market Scenario by Region
- 3.1 Global Acyclovir Sodium Injection Retrospective Market Scenario in Sales by Region: 2017-2022
- 3.2 Global Acyclovir Sodium Injection Retrospective Market Scenario in Revenue by Region: 2017-2022
- 3.3 North America Acyclovir Sodium Injection Market Facts & Figures by Country
- 3.3.1 North America Acyclovir Sodium Injection Sales by Country
4 Global Acyclovir Sodium Injection Historic Market Analysis by Type
- 4.1 Global Acyclovir Sodium Injection Sales Market Share by Type (2017-2022)
- 4.2 Global Acyclovir Sodium Injection Revenue Market Share by Type (2017-2022)
- 4.3 Global Acyclovir Sodium Injection Price by Type (2017-2022)
5 Global Acyclovir Sodium Injection Historic Market Analysis by Application
- 5.1 Global Acyclovir Sodium Injection Sales Market Share by Application (2017-2022)
- 5.2 Global Acyclovir Sodium Injection Revenue Market Share by Application (2017-2022)
- 5.3 Global Acyclovir Sodium Injection Price by Application (2017-2022)
6 Key Companies Profiled
- 6.1 AuroMedics
- 6.1.1 AuroMedics Corporation Information
7 Acyclovir Sodium Injection Manufacturing Cost Analysis
- 7.1 Acyclovir Sodium Injection Key Raw Materials Analysis
- 7.1.1 Key Raw Materials
8 Marketing Channel, Distributors and Customers
- 8.1 Marketing Channel
- 8.2 Acyclovir Sodium Injection Distributors List
- 8.3 Acyclovir Sodium Injection Customers
9 Acyclovir Sodium Injection Market Dynamics
- 9.1 Acyclovir Sodium Injection Industry Trends
- 9.2 Acyclovir Sodium Injection Market Drivers
- 9.3 Acyclovir Sodium Injection Market Challenges
- 9.4 Acyclovir Sodium Injection Market Restraints
10 Global Market Forecast
- 10.1 Acyclovir Sodium Injection Market Estimates and Projections by Type
- 10.1.1 Global Forecasted Sales of Acyclovir Sodium Injection by Type (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
- 12.1 Methodology/Research Approach
- 12.1.1 Research Programs/Design
Acyclovir Sodium Injection is used to treat herpes simplex encephalitis (brain infection with swelling caused by the herpes virus) and herpes infections in newborn infants. Acyclovir injection is in a class of antiviral medications called synthetic nucleoside analogues.
Industry Insights
Due to the COVID-19 pandemic, the global Acyclovir Sodium Injection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Acyclovir Sodium Injection market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Acyclovir Sodium Injection landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
10ml accounting for % of the Acyclovir Sodium Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Herpes Simplex segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Acyclovir Sodium Injection include AuroMedics, Hari Pharma, McGuff Medical Company, Inc., Fresenius Kabi, SteriMax, RxList Inc., Ocean Pharmaceutical, Mits and Dinamics Healthcare Inc., etc. In terms of revenue, the global 3 largest players have a % market share of Acyclovir Sodium Injection in 2021.
This report focuses on Acyclovir Sodium Injection volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Acyclovir Sodium Injection market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Post-covid-19 Outlook
The readers in the section will understand how the Acyclovir Sodium Injection market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Segmental Outlook
Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).
Segment by Type
10ml
20ml
50ml
Others
Segment by Application
Herpes Simplex
Genital Herpes
Herpes Simplex Encephalitis
Neonatal Herpes Infection
Varicella Zoster Infection
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Scenario
In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
AuroMedics
Hari Pharma
McGuff Medical Company, Inc.
Fresenius Kabi
SteriMax
RxList Inc.
Ocean Pharmaceutical
Mits
Dinamics Healthcare Inc.
Xian Medi-Health Co. Ltd
Hebei Lishang Hechuang Sign Co., Ltd.
Frequently Asked Questions
Which product segment grabbed the largest share in the Acyclovir Sodium Injection market?
How is the competitive scenario of the Acyclovir Sodium Injection market?
Which are the key factors aiding the Acyclovir Sodium Injection market growth?
Which are the prominent players in the Acyclovir Sodium Injection market?
Which region holds the maximum share in the Acyclovir Sodium Injection market?
What will be the CAGR of the Acyclovir Sodium Injection market during the forecast period?
Which application segment emerged as the leading segment in the Acyclovir Sodium Injection market?
What key trends are likely to emerge in the Acyclovir Sodium Injection market in the coming years?
What will be the Acyclovir Sodium Injection market size by 2028?
Which company held the largest share in the Acyclovir Sodium Injection market?